Ogilvy CommonHealth Worldwide, a part of WPP Company WPPGY, recently announced two promotions and four new appointments for its US-based offices.
The two promotions were made at Ogilvy CommonHealth Medical Education. Dr. Steven Stockton was promoted from senior medical writer to medical director and Mrs. Amanda Haliszka was promoted to the position of account executive. The new hires include Catherine Goss to Ogilvy CommonHealth Wellness Marketing, Meredith Levy to Ogilvy CommonHealth Medical Marketing and Elizabeth Krieger and Robert Ross to Ogilvy Healthworld. The new hires are expected to majorly contribute towards guiding the company to newer heights.
Ogilvy CommonHealth senior consultants are extremely knowledgeable, with the vast majority holding advanced degrees and are recognized experts in their respective fields. Over the years, this talented human capital has helped clients to solve their complex problems, thus augmenting the company’s revenues. Ogilvy CommonHealth remains focused on driving profitable organic growth by deepening client relationships and creating new revenue generating opportunities via natural extensions of its current offering.
WPP, together with its subsidiaries, provides advertising and communication services globally. The company operates through a number of established global, multinational and national advertising and marketing services companies. Moving forward, WPP expects continued revenue growth, driven by its geographically superior position in new markets, and higher margins by rationalization of operating costs.
WPP currently has a Zacks Rank #2 (Buy). Other stocks that are worth a look now include AirMedia Group Inc. AMCN, The Interpublic Group of Companies, Inc IPG and MDC Partners Inc MDCA, each carrying a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment